I’ve been thinking lately about risk-taking in scientific research, focusing on academia. Yesterday Seth Godin wrote about the nonlinear relationship between risk and reward: small increases in risk can yield large rewards, but only large risks yield the largest rewards. This got me wondering about where pharma is on the risk-taking spectrum, and whether pharma [...]
FluidicMEMS is…
a blog about microfluidics and bioMEMS technologies and how they can help solve real-world problems. Written by Lily Kim, a biomedical-engineer-turned-technology-strategist, FluidicMEMS covers new developments fresh from academia as well as the process of bringing these technologies into the world.
-
Tag Cloud
academia art biomems biomimetic biotech blogging cancer challenges commercialization diagnostic DIY diybio droplets education ethics event food FridayFlick funding globalhealth healthcare Innovation interview jobs killerapp lab-on-a-chip manufacturing marketing medicine meta microbioreactors microfluidics nanotechnology neuroscience news paper pharma point of care policy risk sequencing stemcells venturecapital web2.0 webinar@lilyykim on Twitter
- Di Carlo group: microfluidics for measuring cell deformability as a biomarker for stem cell differentiation http://t.co/cEJhA1rw 2012/05/01
- Pathogenica (pathogen sequencing analysis company) extends deal with US Army, moves from Boston to Cambridge http://t.co/Bvloo2qg 2012/04/20
- Seventh Sense Bios (developing touch-activated painless blood collection) raises $750,000 & apparently has new CEO http://t.co/E6nFK2ZZ 2012/04/19
- CyVek (integrated tests for bioassays, molecular dx and immunodx in drug discovery and point-of-care) raises $3M http://t.co/Hy5JSbVy 2012/04/19
- Helicos sells two pending patents for detecting fetal abnormalities to Sequenom for $1.3M @masshightech http://t.co/HAHBNWIw 2012/04/19